These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33860404)

  • 1. COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified.
    Ferrara F; Pianesi L; Vitiello A
    Immunol Res; 2021 Apr; 69(2):115-116. PubMed ID: 33860404
    [No Abstract]   [Full Text] [Related]  

  • 2. The Need for a Global Network to Cope with Pandemics from Studies of the COVID Infection.
    Kieber-Emmons T
    Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):157-159. PubMed ID: 32996828
    [No Abstract]   [Full Text] [Related]  

  • 3. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.
    Seghatchian J
    Transfus Apher Sci; 2021 Feb; 60(1):103051. PubMed ID: 33461918
    [No Abstract]   [Full Text] [Related]  

  • 4. Plant-based vaccines and antibodies to combat COVID-19: current status and prospects.
    Dhama K; Natesan S; Iqbal Yatoo M; Patel SK; Tiwari R; Saxena SK; Harapan H
    Hum Vaccin Immunother; 2020 Dec; 16(12):2913-2920. PubMed ID: 33270484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibodies for Prevention and Treatment of COVID-19.
    Marovich M; Mascola JR; Cohen MS
    JAMA; 2020 Jul; 324(2):131-132. PubMed ID: 32539093
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 Antibody Trials Have Begun.
    Abbasi J
    JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662848
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 vaccines: one step towards the beginning of the end of the global impact of the pandemic.
    Cook TM; Farrar JJ
    Anaesthesia; 2021 Apr; 76(4):435-443. PubMed ID: 33316853
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response.
    Ramchandani R; Kazatchkine M; Liu J; Sudan P; Dybul M; Matsoso P; Nordström A; Phelan A; Legido-Quigley H; Singh S; Mabuchi S
    BMJ; 2021 Nov; 375():e067488. PubMed ID: 34840135
    [No Abstract]   [Full Text] [Related]  

  • 9. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies may curb pandemic before vaccines.
    Cohen J
    Science; 2020 Aug; 369(6505):752-753. PubMed ID: 32792373
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 and the Swedish enigma.
    Claeson M; Hanson S
    Lancet; 2021 Jan; 397(10271):259-261. PubMed ID: 33357494
    [No Abstract]   [Full Text] [Related]  

  • 12. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?].
    Lanthier L; Carignan A; Plourde MÉ; Cauchon M
    Rev Med Interne; 2021 Mar; 42(3):227-228. PubMed ID: 33612319
    [No Abstract]   [Full Text] [Related]  

  • 14. A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain.
    Niu L; Wittrock KN; Clabaugh GC; Srivastava V; Cho MW
    Front Immunol; 2021; 12():647934. PubMed ID: 33995366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccination and antirheumatic therapy.
    Arnold J; Winthrop K; Emery P
    Rheumatology (Oxford); 2021 Aug; 60(8):3496-3502. PubMed ID: 33710296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on COVID-19: eighteen months on.
    Zacchigna S; Marcello A; Banks L
    FEBS J; 2021 Sep; 288(17):4992-4995. PubMed ID: 34490732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics.
    Su S; Wang Q; Jiang S
    Clin Transl Med; 2021 Jan; 11(1):e284. PubMed ID: 33463059
    [No Abstract]   [Full Text] [Related]  

  • 19. Public opinion on global rollout of COVID-19 vaccines.
    Clarke PM; Roope LSJ; Loewen PJ; Bonnefon JF; Melegaro A; Friedman J; Violato M; Barnett A; Duch R
    Nat Med; 2021 Jun; 27(6):935-936. PubMed ID: 33785911
    [No Abstract]   [Full Text] [Related]  

  • 20. SnapShot: SARS-CoV-2 antibodies.
    Montefiori DC; Acharya P
    Cell Host Microbe; 2021 Jul; 29(7):1162-1162.e1. PubMed ID: 34265246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.